|
1
|
Lepage C, Capocaccia R, Hackl M, Lemmens
V, Molina E, Pierannunzio D, Sant M, Trama A and Faivre J: Survival
in patients with primary liver cancer, gallbladder and extrahepatic
biliary tract cancer and pancreatic cancer in Europe 1999–2007:
Results of EUROCARE-5. Eur J Cancer pii. S0959-8049(15)00714-5.
2015. View Article : Google Scholar
|
|
2
|
Hruban RH and Adsay NV: Molecular
classification of neoplasms of the pancreas. Hum Pathol.
40:612–623. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hahn SA, Schutte M, Hoque AT, Moskaluk CA,
da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban
RH and Kern SE: DPC4, a candidate tumor suppressor gene at human
chromosome 18q21.1. Science. 271:350–353. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oshima M, Okano K, Muraki S, Haba R, Maeba
T, Suzuki Y and Yachida S: Immunohistochemically detected
expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4)
strongly predicts survival in patients with resectable pancreatic
cancer. Ann Surg. 258:336–346. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Singh P, Srinivasan R and Wig JD: SMAD4
genetic alterations predict a worse prognosis in patients with
pancreatic ductal adenocarcinoma. Pancreas. 41:541–546. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Blackford A, Serrano OK, Wolfgang CL,
Parmigiani G, Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ,
Eshleman JR, et al: SMAD4 gene mutations are associated with poor
prognosis in pancreatic cancer. Clin Cancer Res. 15:4674–4679.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McCarthy DM, Hruban RH, Argani P, Howe JR,
Conlon KC, Brennan MF, Zahurak M, Wilentz RE, Cameron JL, Yeo CJ,
et al: Role of the DPC4 tumor suppressor gene in adenocarcinoma of
the ampulla of Vater: analysis of 140 cases. Mod Pathol.
16:272–278. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J, Tang R, Lv M, Wang Q, Zhang X, Guo
Y, Chang H, Qiao C, Xiao H, Li X, et al: Defective anchoring of
JNK1 in the cytoplasm by MKK7 in Jurkat cells is associated with
resistance to Fas-mediated apoptosis. Mol Biol Cell. 22:117–127.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takekawa M, Tatebayashi K and Saito H:
Conserved docking site is essential for activation of mammalian MAP
kinase kinases by specific MAP kinase kinase kinases. Mol Cell.
18:295–306. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Y, Gorospe M, Yang C and Holbrook NJ:
Role of mitogen-activated protein kinase phosphatase during the
cellular response to genotoxic stress. Inhibition of c-Jun
N-terminal kinase activity and AP-1-dependent gene activation. J
Biol Chem. 270:8377–8380. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo Y, Wang W, Wang J, Feng J, Wang Q, Jin
J, Lv M, Li X, Li Y, Ma Y, et al: Receptor for activated C kinase 1
promotes hepatocellular carcinoma growth by enhancing
mitogen-activated protein kinase kinase 7 activity. Hepatology.
57:140–151. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sakurai T, Maeda S, Chang L and Karin M:
Loss of hepatic NF-kappa B activity enhances chemical
hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1
activation. Proc Natl Acad Sci USA. 103:10544–10551. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kuntzen C, Sonuc N, De Toni EN, Opelz C,
Mucha SR, Gerbes AL and Eichhorst ST: Inhibition of
c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced
apoptosis and induces G2/M cell cycle arrest. Cancer Res.
65:6780–6788. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pearson G, Robinson F, Beers Gibson T, Xu
BE, Karandikar M, Berman K and Cobb MH: Mitogen-activated protein
(MAP) kinase pathways: Regulation and physiological functions.
Endocr Rev. 22:153–183. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takahashi R, Hirata Y, Sakitani K, Nakata
W, Kinoshita H, Hayakawa Y, Nakagawa H, Sakamoto K, Hikiba Y,
Ijichi H, et al: Therapeutic effect of c-Jun N-terminal kinase
inhibition on pancreatic cancer. Cancer Sci. 104:337–344. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thornley JA, Trask HW, Ringelberg CS,
Ridley CJ, Wang S, Sal-Lari RC, Moore JH, Korc M and Tomlinson CR:
SMAD4-dependent polysome RNA recruitment in human pancreatic cancer
cells. Mol Carcinog. 51:771–782. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Derynck R and Zhang YE: Smad-dependent and
Smad-independent pathways in TGF-beta family signalling. Nature.
425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hayashida T, Decaestecker M and Schnaper
HW: Cross-talk between ERK MAP kinase and Smad signaling pathways
enhances TGF-beta-dependent responses in human mesangial cells.
FASEB J. 17:1576–1578. 2003.PubMed/NCBI
|
|
20
|
He S, Liu X, Yang Y, Huang W, Xu S, Yang
S, Zhang X and Roberts MS: Mechanisms of transforming growth factor
beta(1)/Smad mediated by mitogen-activated protein kinase pathways
in keloid fibroblasts. Br J Dermatol. 162:538–546. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cui J, Wang Q, Wang J, Lv M, Zhu N, Li Y,
Feng J, Shen B and Zhang J: Basal c-Jun NH2-terminal protein kinase
activity is essential for survival and proliferation of T-cell
acute lymphoblastic leukemia cells. Mol Cancer Ther. 8:3214–3222.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang J, Wang Q, Zhu N, Yu M, Shen B,
Xiang J and Lin A: Cyclic AMP inhibits JNK activation by
CREB-mediated induction of c-FLIP(L) and MKP-1, thereby
antagonizing UV-induced apoptosis. Cell Death Differ. 15:1654–1662.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA,
Bennett AM and Flavell RA: Dynamic regulation of pro- and
anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate
immune responses. Proc Natl Acad Sci USA. 103:2274–2279. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kinney CM, Chandrasekharan UM, Mavrakis L
and DiCorleto PE: VEGF and thrombin induce MKP-1 through distinct
signaling pathways: Role for MKP-1 in endothelial cell migration.
Am J Physiol Cell Physiol. 294:C241–C250. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kwon GT, Cho HJ, Chung WY, Park KK, Moon A
and Park JH: Isoliquiritigenin inhibits migration and invasion of
prostate cancer cells: Possible mediation by decreased JNK/AP-1
signaling. J Nutr Biochem. 20:663–676. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li M, Feurino LW, Li F, Wang H, Zhai Q,
Fisher WE, Chen C and Yao Q: Thymosinalpha1 stimulates cell
proliferation by activating ERK1/2, JNK, and increasing cytokine
secretion in human pancreatic cancer cells. Cancer Lett. 248:58–67.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yamagata H, Matsuzaki K, Mori S, Yoshida
K, Tahashi Y, Furukawa F, Sekimoto G, Watanabe T, Uemura Y, Sakaida
N, et al: Acceleration of Smad2 and Smad3 phosphorylation via c-Jun
NH(2)-terminal kinase during human colorectal carcinogenesis.
Cancer Res. 65:157–165. 2005.PubMed/NCBI
|
|
29
|
Itatani Y, Kawada K, Fujishita T, Kakizaki
F, Hirai H, Matsumoto T, Iwamoto M, Inamoto S, Hatano E, Hasegawa
S, et al: Loss of SMAD4 from colorectal cancer cells promotes CCL15
expression to recruit CCR1+ myeloid cells and facilitate
liver metastasis. Gastroenterology. 145:1064–1075. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aitchison AA, Veerakumarasivam A, Vias M,
Kumar R, Hamdy FC, Neal DE and Mills IG: Promoter methylation
correlates with reduced Smad4 expression in advanced prostate
cancer. Prostate. 68:661–674. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gururajan M, Chui R, Karuppannan AK, Ke J,
Jennings CD and Bondada S: c-Jun N-terminal kinase (JNK) is
required for survival and proliferation of B-lymphoma cells. Blood.
106:1382–1391. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hahn JN, Falck VG and Jirik FR: Smad4
deficiency in T cells leads to the Th17-associated development of
premalignant gastroduodenal lesions in mice. J Clin Invest.
121:4030–4042. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen YW, Hsiao PJ, Weng CC, Kuo KK, Kuo
TL, Wu DC, Hung WC and Cheng KH: SMAD4 loss triggers the phenotypic
changes of pancreatic ductal adenocarcinoma cells. BMC Cancer.
14:1812014. View Article : Google Scholar : PubMed/NCBI
|
